Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Locally Advanced Pancreas Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Looking for participantsNCT06435260
What this trial is testing

Hypofractionated Radiotherapy +Chemotherapy+ Camrelizumab as Neoadjuvant Therapy for Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Hebei Medical University Fourth Hospital 30
Not applicableLooking for participantsNCT05679674
What this trial is testing

Stereotactic Body Radiation and Tumor Treating Fields for Locally Advanced Pancreas Cancer

Who this might be right for
Pancreas CancerLocally AdvancedLocally Advanced Pancreatic Adenocarcinoma
Baptist Health South Florida 48
Early research (Phase 1)Ended earlyNCT05631574
What this trial is testing

Study of Covalent Menin Inhibitor BMF-219 in Adult Patients With KRAS Driven Non-Small Cell Lung Cancer, Pancreatic Cancer, and Colorectal Cancer

Who this might be right for
Non Small Cell Lung CancerPancreatic CancerColorectal Cancer+14 more
Biomea Fusion Inc. 13
Testing effectiveness (Phase 2)Study completedNCT01601808
What this trial is testing

Clinical Trial Comparing Gemcitabine and Vandetanib Therapy With Gemcitabine Alone in Pancreatic Carcinoma

Who this might be right for
Pancreatic Cancer
University of Liverpool 142
Testing effectiveness (Phase 2)Study completedNCT02035072
What this trial is testing

Phase II Study of Hypofractionated Radio-chemotherapy With Gemcitabine Plus Oxaliplatin for Unresectable Nonmetastatic Locally Advanced Pancreatic Cancer.

Who this might be right for
Unresectable Pancreatic CancerNonmetastatic Pancreatic CancerLocally Advanced Pancreatic Cancer
Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS 40
Large-scale testing (Phase 3)Study completedNCT00192712
What this trial is testing

Irinotecan, Gemcitabine and Radiation Therapy for Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Rambam Health Care Campus 20
Early research (Phase 1)Not Yet RecruitingNCT07699757
What this trial is testing

HSK41959 With Standard Therapy in Solid Tumors With MTAP Deletion

Who this might be right for
Non-Small Cell Lung CancerPancreatic Ductal Adenocarcinoma (mPDAC)Advanced Solid Tumors
Haisco Pharmaceutical Group Co., Ltd. 258
Testing effectiveness (Phase 2)Looking for participantsNCT06538857
What this trial is testing

CEB-01 in Locally Resectable Pancreatic Cancer

Who this might be right for
Pancreatic Carcinoma
CEBIOTEX 39
Testing effectiveness (Phase 2)Looking for participantsNCT07595172
What this trial is testing

NALIRIFOX+Adebrelimab+PULSAR for Advanced Pancreatic Cancer

Who this might be right for
Pancreatic Ductal Adenocarcinoma (PDAC)Locally Advanced and Metastatic Pancreatic Cancer
West China Hospital 55
Not applicableStudy completedNCT02704143
What this trial is testing

Combination of SBRT With Sequential S-1 for Treating Locally Advanced Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Changhai Hospital 63
Early research (Phase 1)Study completedNCT02227940
What this trial is testing

Ceritinib and Combination Chemotherapy in Treating Patients With Advanced Solid Tumors or Locally Advanced or Metastatic Pancreatic Cancer

Who this might be right for
Advanced Malignant Solid NeoplasmALK PositiveMetastatic Pancreatic Adenocarcinoma+2 more
Roswell Park Cancer Institute 38
Not applicableLooking for participantsNCT06026943
What this trial is testing

Alpha Radiation Emitters for the Treatment of Pancreatic Cancer for the Treatment of Locally Advanced Pancreatic Cancer

Who this might be right for
Pancreatic CancerUnresectable Pancreatic CancerPancreatic Adenocarcinoma
Alpha Tau Medical LTD. 15
Early research (Phase 1)WithdrawnNCT02159248
What this trial is testing

Tolfenamic Acid, Gemcitabine and Radiation for Locally Advanced or Metastatic Pancreatic Cancer Requiring Radiation

Who this might be right for
Pancreatic Cancer
Orlando Health, Inc.
Early research (Phase 1)Study completedNCT01486329
What this trial is testing

VXM01 Phase I Dose Escalation Study in Patients With Locally Advanced, Inoperable and Stage IV Pancreatic Cancer

Who this might be right for
Stage IV Pancreatic Cancer
Vaximm GmbH 72
Testing effectiveness (Phase 2)UnknownNCT01182246
What this trial is testing

AXP107-11 in Combination With Standard Gemcitabine (Gemzar® ) Therapy for Treatment in Patients With Pancreatic Cancer

Who this might be right for
Adenocarcinoma
Axcentua Pharmaceuticals AB 44
Early research (Phase 1)Active Not RecruitingNCT05083780
What this trial is testing

Hydroxychloroquine and Chlorphenesin Carbamate in Combination With mFOLFIRINOX in Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Changhoon Yoo 40
Testing effectiveness (Phase 2)Study completedNCT00026403
What this trial is testing

Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Advanced Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Alliance for Clinical Trials in Oncology 48
Testing effectiveness (Phase 2)Ended earlyNCT00948688
What this trial is testing

Vorinostat With XRT and 5-FU for Locally Advanced Adenocarcinoma of the Pancreas

Who this might be right for
Pancreatic CancerAdenocarcinoma of the Pancreas
Massachusetts General Hospital 10
Not applicableEnded earlyNCT00660348
What this trial is testing

Standard Pain Control or Intrathecal Therapy in Controlling Pain in Patients With Locally Advanced, Unresectable, or Metastatic Pancreatic Cancer

Who this might be right for
PainPancreatic Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 1
Testing effectiveness (Phase 2)Looking for participantsNCT05988814
What this trial is testing

Trial Evaluating the Efficacy and the Safety of FOLFIRINOX3 Treatment in Patients With Unresectable Locally Advanced or Metastatic Pancreatic Cancer in First Line of Chemotherapy

Who this might be right for
Metastatic Pancreatic Cancer
Centre Georges Francois Leclerc 90
Next Page